Psychosocial Needs Remain Largely Unmet for Patients with Lung Cancer, Caregivers

Cigarette Sales Up in U.S. for the First Time in 20 Years

Studies Question Further Modification of pTNM Staging as 9th Edition Deadline Approaches

New Warranty, Rebate Programs Put Spotlight on Value in Lung Cancer

Rare NUT Carcinoma Gaining Recognition in Lung Cancer Community

Assay that Combines Clinical, Radiomic Characteristics with CT Information Shown to Better Distinguish Malignant Early Lung Nodules

Atezolizumab Approved for Adjuvant NSCLC Therapy for Patients with Stage II-IIIA Disease, PD-L1 ≥ 1%

Adoption of VATS Continues to Vary Globally

First New Second-line Therapy for SCLC in Australia in 20 Years

Sotorasib Scores Second-line Approval in Canada

Savolitinib Approved in China for MET-Positive NSCLC

Durvalumab Plus Chemotherapy Approved in China as First-Line Management of Extensive-stage SCLC